Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Iridex Granted European Patent for MicroPulse Technology
Iridex, a pioneering company in the field of medical devices, announced the grant of the European Patent ‘EP 3009093.’ This patent, titled “Laser System with Short Pulse Characteristics and its Methods of Use,” signifies a significant milestone for the company,…
Negative Effect of Atropine Drops After Glaucoma Surgery
According to a report by an international team of researchers, atropine instillation after trabeculectomy should be discouraged since it causes greater and longer lasting reduction in visual quality.1 The study’s lead author is Panagiotis Laspas, MD, of the Department of…
Perfluorohexyloctane Drops Help Alleviate Dry Eye
According to recent research, perfluorohexyloctane eye drops (SHR8058) demonstrated significant improvement in both the signs and symptoms of dry eye disease (DED) linked to meibomian gland dysfunction (MGD) with rapid effectiveness in Chinese patients. The findings showed that the perfluorohexyloctane…
Treatment of Intraocular Melanoma | OBN
Melanoma of the uveal tract (iris, ciliary body, and choroid), though rare, is the most common primary intraocular malignancy in adults. The mean age-adjusted incidence of uveal melanoma in the United States is approximately 4.3 new cases per million people,…
4DMT Reports Positive Interim Data for Wet AMD Treatment
4D Molecular Therapeutics (4DMT) announced positive interim data from the Phase 2 PRISM clinical trial, marking a significant stride in the treatment of wet age-related macular degeneration (wet AMD). Arshad M. Khanani, MD, MA, FASRS, presented the data at the…
Kiora, Théa Partner for Retinal Disease Treatment
Kiora Pharmaceuticals has joined forces with Théa Open Innovation (TOI), a sister company of Laboratoires Théa, to develop and commercialize KIO-301 for the treatment of degenerative retinal diseases. The strategic agreement grants Théa exclusive worldwide development and commercialization rights, excluding…
UMass Chan Grants Gene Therapy Licenses to Iveric Bio
UMass Chan Medical School has awarded exclusive global rights for the development and commercialization of innovative adeno-associated virus (AAV) gene therapy products targeting Stargardt disease and Leber congenital amaurosis type 10 (LCA10) to Iveric Bio, an Astellas Company. While gene…
Researcher Cautions on Low-Level Red Light for Myopia
A cautionary note has been sounded by a researcher from the University of Houston’s College of Optometry regarding the use of low-level red light (LLRL) therapy for controlling myopia, particularly in children. Despite recent studies touting its effectiveness in reducing…
Reginald J. Sanders, M.D. Named as New President of the ASRS
Dr. Reginald J. Sanders, a distinguished physician affiliated with the Retina Group of Washington (RGW) and PRISM Vision Group, has been named as the new president of the American Society of Retina Specialists (ASRS). Dr. Sanders holds the distinction of…
FDA Approves Modified Axpaxli Trial by Ocular Therapeutix
Ocular Therapeutix announced that the FDA has granted approval for a modification to the special protocol assessment (SPA) agreement for the pivotal phase 3 SOL clinical trial of Axpaxli (axitinib intravitreal implant, also known as OTX-TKI). This modification marks a…